Clinical trial

Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer

NCT04377152

StatusAPPROVED_FOR_MARKETING

Study typeEXPANDED_ACCESS

Start dateUnknown

PhaseN/A

Study timeline

Registry last updated2021-03-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Prostateunresolved

Prostate Adenocarcinomaunresolved

Interventions

68Gallium-PSMA-11DRUG

Positron Emission Tomography (PET)PROCEDURE

Sponsors & collaborators

University of California, San Franciscolead sponsor

Mapped research locations

San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04377152 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.